Generating Real‐World Evidence From the Excellence Network in Rheumatology
- 11 December 2024
- journal article
- research article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 33 (12) , e70067
Abstract
Purpose: The Excellence Network in RheumatoloGY (ENRGY) was founded in 2021 and encompasses data from more than 700 private practice rheumatology providers throughout the United States, forming a practice‐based research network (PBRN).Methods: Electronic health record (EHR) data from participating practices are aggregated, including structured data (e.g., clinical assessments) and unstructured data from two different EHR platforms. Targeted data quality efforts ensure capture of high‐quality clinical data and reduce missingness. ENRGY network membership also provides participating sites access to technology services that enhance patient care. Centralized ethics approval and pre‐existing legal agreements along with electronic tools to curate data and contact eligible study participants improves efficiency of multi‐center prospective studies.Results: The ENRGY data warehouse includes linked administrative claims data for commercial and government‐provided insurance (31% of patients linked to commercial claims) and patient‐generated health data from both in‐office and out‐of‐office settings via a smartphone app as well as biosensor data. ENRGY data and infrastructure can be employed to identify the highest yield sites for prospective studies; identify patients meeting study eligibility criteria; pre‐screen individual patient's willingness to participate in specific studies; centralize study data monitoring; and assist in the conduct of prospective studies.Conclusion: ENRGY data have been used to generate a growing number of scientific publications and may serve as a model for PBRNs in other specialties seeking to harness the potential of data linkages, patient‐generated data capture, and centralized study infrastructure for observational and interventional research.Keywords
Funding Information
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (P30AR072583)
This publication has 18 references indexed in Scilit:
- Changes in the Workforce Characteristics of Providers Who Care for Adult Patients With Rheumatologic and Musculoskeletal Disease in the United StatesArthritis & Rheumatology, 2024
- Using Electronic Health Records and Linked Claims Data to Assess New Medication Use and Primary Nonadherence in Rheumatology PatientsArthritis Care & Research, 2024
- Privacy‐preserving record linkage across disparate institutions and datasets to enable a learning health system: The national COVID cohort collaborative (N3C) experienceLearning Health Systems, 2024
- Enhancing the identification of rheumatoid arthritis-associated interstitial lung disease through text mining of chest computerized tomography reportsSeminars in Arthritis and Rheumatism, 2023
- Assessing the impact of privacy-preserving record linkage on record overlap and patient demographic and clinical characteristics in PCORnet®, the National Patient-Centered Clinical Research NetworkJournal of the American Medical Informatics Association, 2022
- Machine Learning Applied to Patient‐Reported Outcomes to Classify Physician‐Derived Measures of Rheumatoid Arthritis Disease ActivityACR Open Rheumatology, 2022
- The Economic Benefit of Remission for Patients with Rheumatoid ArthritisRheumatology and Therapy, 2022
- Medication Interruptions and Subsequent Disease Flares During the COVID‐19 Pandemic: A Longitudinal Online Study of Patients With Rheumatic DiseaseArthritis Care & Research, 2022
- Patient-Reported Nausea and Fatigue Related to Methotrexate: A Prospective, Self-Controlled Study in the ArthritisPower® RegistryRheumatology and Therapy, 2021
- Social Distancing, Health Care Disruptions, Telemedicine Use, and Treatment Interruption During the COVID‐19 Pandemic in Patients With or Without Autoimmune Rheumatic DiseaseACR Open Rheumatology, 2021